期刊文献+

雌激素依赖型与非雌激素依赖型子宫内膜癌临床病理特征的研究 被引量:7

A Study on the Clinicopathological Characteristics of Estrogen-Dependent and Estrogen-Independent Endometrial Carcinoma
下载PDF
导出
摘要 目的:研究雌激素依赖型(Ⅰ型)和非雌激素依赖型(Ⅱ型)子宫内膜癌的临床病理特征。方法:根据患者是否存在雌激素的高危因素,将162例子宫内膜癌患者分为Ⅰ型及Ⅱ型,并对两型的临床病理特征进行回顾性分析。结果:Ⅰ型患者占72.8%,Ⅱ型占27.2%,Ⅱ型以绝经后患者多见。具有较高恶性程度的非内膜样腺癌(包括透明细胞癌、浆液性腺癌)在Ⅱ型中占13.6%,在Ⅰ型中仅占4.2%(P< 0.05)。Ⅱ型患者的分级以中、低分化多见;Ⅱ型的深肌层浸润、淋巴转移率和腹腔细胞学阳性率明显高于Ⅰ型(P分别< 0.01),手术Ⅲ、Ⅳ期的比率较Ⅰ型亦有显著增加(P< 0.05)。结论:非雌激素依赖型(Ⅱ型)子宫内膜癌分级高,肌层浸润深,分期晚,容易出现转移,预后不好。 Objective To investigate the clinicopathological characteristics of estrogen-dependent typeⅠ and estrogen-independent typeⅡ endometrial carcinoma. Methods The clinicopathological features of 162 cases of endometrial carcinoma were analysed retrospectively according to whether or not the genesis of tumor was dependent on estrogen. Results The incidence of typeⅠand type Ⅱ were 72.8% and 27.2% respectively The rate of postmenopause patients in type Ⅱ was significantly higher than that in typeⅠ 79.5% vs 52.5% P< 0.05. There were more virulent types of nonendometrioid carcinoma serous adenocarcinoma clear cell adenocarcinoma in typeⅡ as compared with typeⅠ13.6% vs 4.2% P< 0.05. The rate of high grade grade 2 3 deep myometrial invasion lymph node metastasis and peritoneal cytology positive in typeⅡ were higher than those in type I respectively 68.2% 50.0% 19.0% 27.5% vs 46.6% 23.7% 5.2% 11.8% P< 0.05. The patients with surgical stage Ⅲ or Ⅳ in typeⅡ were more than those in type I P< 0.05. Conclusion The estrogen-independent endometrial carcinoma type Ⅱ is a more malignant type with high grade deep myometrial invasion late stage and frequent lymph node metastasis. The prognosis of type Ⅱ
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2000年第9期682-685,共4页 Chinese Journal of Clinical Oncology
关键词 子宫内膜癌 雌激素依赖型 非雌激素依赖型 病理 Endometrial carcinoma Estrogen-dependent  typeⅠ is worse than that of typeⅠ. Estrogen-independent type Ⅱ Clinical-pathol
  • 相关文献

参考文献1

共引文献9

同被引文献73

  • 1Abdel-Rahman N. Zekri,Gelane M. Sabry,Abeer A. Bahnassy,Kamal A. Shalaby,Sabrin A.Abdel-Wahabh,Serag Zakaria.Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6,HMSH2) in the pathogenesis of hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(20):3020-3026. 被引量:10
  • 2詹娜,黎辉,王则胜,熊永炎.子宫内膜透明细胞癌的免疫组化研究[J].诊断病理学杂志,2006,13(2):85-88. 被引量:3
  • 3杨蕾,秦占芬,蒋湘宁,徐晓白.雌激素致乳腺癌机制的研究进展[J].肿瘤防治研究,2006,33(11):840-842. 被引量:7
  • 4董学斌,纪春岩,马道新,马榕,臧绍蕾,余海青,郭冬梅.Notch信号在人类乳腺癌中的作用[J].中华肿瘤杂志,2007,29(6):425-428. 被引量:14
  • 5Le K, Liu Y, Mo JQ, et al. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in haman breast cancer[ J]. Bmc Cancer, 2008,8 : 158.
  • 6Hunter SG, Zhuang G, Sieders DB, et al. Essential role of Vav family guanine nucleotlde exchange factors in EphA receptor-mediated angiogenesis[ J]. Mol Cell Bio, 2006,26( 13 ) :4830-4842.
  • 7Zeng L, Sachdev P, Yah L, et al. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces call transformation [ J ]. Mol Cell, 2000, 20(24) :9212-9224.
  • 8Todd RP, Karon A, Antoine EK, et al. Vav transformation requires activation of multiple GTPasns and regulation of gene expression [ J]. Mol Cancer Res, 200412 (12) :702-711.
  • 9Yamaguchi Y. Microenvironmental regulation of estrogen signals in breast cancer[J]. Breast Cancer, 2007,14(2) :175-181.
  • 10Sorosky JI.Endometrial Cancer.Obstet Gynecol,2008,111(2):436-447.

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部